Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 16, 2019
Outcomes of Hematopoietic Cell Transplantation in Patients with Germline SAMD9/SAMD9L MutationsIbrahim A Ahmed, Midhat S Farooqi, Mark T Vander Lugt, et al.
Journal for Immunotherapy of Cancer|January 21, 2021
Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infectionErin M Hall, Dwight E Yin, Rakesh K Goyal, et al.
Blood|October 22, 2008
TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurementsHong-Yan Du, Elena Pumbo, Jennifer Ivanovich, et al.
Blood|February 6, 2014
The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trialMichael A Pulsipher, Bryan Langholz, Donna A Wall, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 2, 2014
TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521)Gregory A Yanik, Stephan A Grupp, Michael A Pulsipher, et al.
Blood Advances|September 1, 2019
Related and unrelated donor transplantation for β-thalassemia major: results of an international surveyChunfu Li, Vikram Mathews, Soyoung Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 19, 2010
Advancement of pediatric blood and marrow transplantation research in North America: priorities of the Pediatric Blood and Marrow Transplant ConsortiumMichael A Pulsipher, Edwin M Horwitz, Ann E Haight, et al.
Transfusion|January 21, 2021
A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disordersNabanita Bhunia, Rolla Abu-Arja, Joseph R Stanek, et al.
Nature Genetics|October 13, 2015
The genomic landscape of juvenile myelomonocytic leukemiaElliot Stieglitz, Amaro N Taylor-Weiner, Tiffany Y Chang, et al.
Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56<sup>bright</sup> NKG2A<sup>+++</sup> Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.
Pageof 5